SMS Pharmaceuticals Ltd Quarterly Results

Gross Sales

242.43

196.05

248.2

173.35

196.75

Excise Duty

0

0

0

0

0

Net Sales

242.43

196.05

248.2

173.35

196.75

Other Operating Income

0

0

0

0

0

Other Income

1.43

0.59

1.42

2.13

1.3

Total Income

243.86

196.64

249.62

175.48

198.05

Total Expenditure

194.06

156.68

207.39

140.14

165.28

PBIDT

49.8

39.96

42.23

35.34

32.77

Interest

5.74

5.84

5.07

4.2

4.61

PBDT

44.06

34.12

37.16

31.13

28.16

Depreciation

10.02

9.75

8.64

8.7

8.62

Minority Interest Before NP

0

0

0

0

0

Tax

8.25

5

4.65

4.99

4.7

Deferred Tax

0.66

0.65

3.79

0.37

0.98

Reported Profit After Tax

25.13

18.71

20.08

17.08

13.86

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

25.31

20.49

20.32

18.24

14.1

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

25.31

20.49

20.32

18.24

14.1

EPS (Unit Curr.)

2.84

2.31

2.4

2.15

1.67

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

9.37

8.87

8.87

8.47

8.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.54

20.38

17.01

20.38

16.65

PBDTM(%)

18.17

17.4

14.97

17.95

14.31

PATM(%)

10.36

9.54

8.09

9.85

7.04